Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS National Generic Pharmaceuticals - Wave 15c

NHS England

This public procurement record has 8 releases in its history.

Award

26 Feb 2026 at 11:26

UK7 - Contract Details Notice
Award

14 Jan 2026 at 09:18

UK6 - Contract Award Notice
TenderUpdate

10 Sep 2025 at 14:19

UK4 - Tender Notice
TenderUpdate

10 Sep 2025 at 14:00

UK4 - Tender Notice
TenderUpdate

04 Sep 2025 at 16:19

UK4 - Tender Notice
Tender

02 Sep 2025 at 11:48

UK4 - Tender Notice
Planning

14 Aug 2025 at 15:27

UK2 - Preliminary Market Engagement Notice
Planning

20 May 2025 at 15:48

UK1 - Pipeline Notice
Summary of the contracting process

In a recent public procurement process, NHS England, headquartered in London, has completed the award stage of the NHS National Generic Pharmaceuticals framework, titled 'Wave 15c'. The procurement utilised an open procedure and is covered by the GPA. This initiative spans multiple regions across the United Kingdom, including London, South Yorkshire, North East, and others, targeting the provision of pharmaceutical products. The framework allows call-offs for varying periods, with an option to extend up to 48 months. The contract valued at above £669 million gross, commenced its award on 13th January 2026, with contract periods starting from 1st June 2026 and lasting as detailed in the individual lots.

This procurement process presents a substantial opportunity for pharmaceutical suppliers to engage with NHS England, potentially boosting their business growth through long-term contracts. It involves three distinct lots, including oral and hospital-only products. Suppliers ranging from SMEs to large organisations across the UK and internationally competed, making it an inclusive opportunity for diverse business types. This initiative may particularly benefit businesses specialising in pharmaceuticals capable of operating at scale in competitive supply environments, offering medical supplies to regions within the specified framework. With NHS England as the primary contracting authority, successful bidders include well-known names such as Celix Pharma Ltd, Martindale Pharma, and Teva UK Limited, among others. The availability of extension options further enhances the scope for sustained growth and partnership opportunities within NHS supply chains.

How relevant is this notice?

Notice Information

Notice Title

NHS National Generic Pharmaceuticals - Wave 15c

Notice Description

NHS National Framework for Generic Pharmaceuticals - Wave 15c Offer reference number: CM/PHG/23/5699 Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: CM/PHG/23/5699/01 Oral (plus non-parenteral) products CESW/LSNE/NWLN 01/06/2026 to 31/05/2027 (12 months) CM/PHG/23/5699/02 Hospital only products DLS: 01/06/2026 to 31/05/2028 (24 months) DNE: 01/06/2026 to 31/05/2028 (24 months) CM/PHG/23/5699/03 Hospital only (housekeeping) products DLN/DNW 01/06/2026 to 31/01/2027 (8 months) DCE/DSW 01/06/2026 to 30/09/2027 (16 months)

Lot Information

Lot 1 - CM/PHG/23/5699/01 Oral (plus non-parenteral) products

Potential periods of call-offs under the framework agreement: CM/PHG/23/5699/01 Oral (plus non-parenteral) products: CESW/LSNE/NWLN 01/06/2026 to 31/05/2027 (12 months)

Options: Option or options to extend (at the authority's discretion) for a period or periods up to a total of 24 months.

Renewal: Option or options to extend (at the authority's discretion) for a period or periods up to a total of 24 months.

Lot 2 - CM/PHG/23/5699/02 CM/PHG/23/5699/02 Hospital only products

Potential periods of call-offs under the framework agreement: CM/PHG/23/5699/02 CM/PHG/23/5699/02 Hospital only products: DLS: 01/06/2026 to 31/05/2028 (24 months) DNE: 01/06/2026 to 31/05/2028 (24 months)

Options: Option or options to extend (at the authority's discretion) for a period or periods up to a total of 48 months.

Renewal: Option or options to extend (at the authority's discretion) for a period or periods up to a total of 48 months.

Lot 3 - CM/PHG/23/5699/03 Hospital only (housekeeping) products

Potential periods of call-offs under the framework agreement: CM/PHG/23/5699/03 Hospital only (housekeeping) products: DLN/DNW 01/06/2026 to 31/01/2027 (8 months) DCE/DSW 01/06/2026 to 30/09/2027 (16 months)

Options: Option or options to extend (at the authority's discretion) for a period or periods up to a total of 32 months.

Renewal: Option or options to extend (at the authority's discretion) for a period or periods up to a total of 32 months.

Planning Information

NHS England is advising suppliers of an upcoming tender for the NHS National Framework Agreement for the supply of Generic Pharmaceuticals, Wave 15c to commence on 1st June 2026 for varying dates of up to 24 months with the option to extend for a further 24 months. This procurement will largely consist of hospital only products in the London South and North East regions, and will also include hospital only products in the remaining regions and oral products (plus non-parenterals) in all regions. The purpose of this notice is to inform existing and potential new suppliers of this procurement. Useful information for suppliers can be found here: https://www.england.nhs.uk/medicines-2/medicines-value-and-access/medicines-procurement-and-supply-chain/ and the current generics workplan here: https://www.england.nhs.uk/publication/generics-framework-workplan-by-product-report/ . Specific information regarding the products included in this procurement will be provided in the ITO, which will be issued shortly.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-05193a
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/017220-2026
Current Stage
Award
All Stages
Planning, Tender, Award

Procurement Classification

Notice Type
UK7 - Contract Details Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
SME
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£557,571,000 £100M-£1B
Lots Value
£557,571,000 £100M-£1B
Awards Value
£458,589,000 £100M-£1B
Contracts Value
£458,589,000 £100M-£1B

Notice Dates

Publication Date
26 Feb 20266 months ago
Submission Deadline
10 Oct 2025Expired
Future Notice Date
2 Sep 2025Expired
Award Date
13 Jan 20267 months ago
Contract Period
1 Jun 2026 - 30 Sep 2027 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SE1 8UG
Postcode Area
South East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI45 Lambeth
Delivery Location
TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLI London, TLJ South East (England), TLK South West (England)
Local Authority
Lambeth
Electoral Ward
Waterloo & South Bank
Westminster Constituency
Vauxhall and Camberwell Green

Supplier Information

Number of Suppliers
105
Supplier Names

AFT Pharma UK

AGB Pharma

AOP Orphan Ltd

Accord UK Ltd

Aguettant Ltd

Alturix Limited

Amarox Limited

Arcadia Pharma Ltd T/A Arcadia Medical

Ascend Laboratories UK Ltd

Ascot Laboratories Ltd

Aspen Pharmacare UK Limited

Aspire Pharma Limited

Aventis Pharma ltd t/a Sanofi

B Braun Medical Limited

Baxter Healthcare Ltd

Beaumont Pharma Ltd

Biocon

Bowmed Ibisqus Limited

Brown & Burk UK Ltd

CST Pharma Limited

Celix Pharma Ltd

Chiesi Limited

Cipla

Colonis Pharma Ltd

Consilient Health Ltd

Crescent Pharma Ltd

Day Lewis Medical Ltd

Desitin Pharma Ltd

Dr.Reddy's Laboratories (UK) Limited

Drugsrus Ltd

Ennogen Healthcare Ltd

Eramol (UK) Ltd

Essential Pharma

Esteve Pharmaceuticals Ltd

Farmak Pharmaceuticals

Flexipharm Austrading Limited

Flynn Pharma Ltd

Fontus Health Ltd

Fresenius Kabi Limited

G.L. Pharma UK Limited

Galen Limited

Galvany Pharma Ltd

Gennisium Pharma

GlaxoSmithKline UK Limited

Glenmark Pharmaceuticals Europe Limited

Green Park Pharma Ltd

Grindeks Kalceks UK Ltd

Hameln Pharma Ltd

Hikma Pharmaceuticals

JCSH Pharma Ltd

Kent Pharma Ltd

Leo Pharma

Lipomed AG

LogixX Pharma Ltd

Lucane Pharma

Lundbeck Limited

MSN Laboratories Europe Limited

Macleods Pharma UK Limited

Macure Pharma ApS

Martindale Pharma

Merck Sharpe & Dohme (UK) Limited

Mercury Pharmaceuticals

Milpharm Ltd

Morningside Pharmaceuticals

Necessity Supplies Limited

Neon Healthcare Ltd

Neuraxpharm UK Ltd

Northumbria Pharma Limited

Novumgen Limited

Orifarm UK Ltd

Otsuka Pharmaceuticals UK Limited

Panpharma UK Limited

Pari Medical Limited

Perennial Pharma Ltd

Pfizer Ltd

Phoenix Lab

Piramal Critical care Limited

ROVI Biotech Ltd

RPH Pharmaceuticals AB

Reig Jofre UK limited

Roche Products Ltd

Roma Pharmaceuticals Limited

Rosemont Pharmaceuticals Limited

SVP Pharma Ltd

Sandoz Ltd

Seacross Pharmaceuticals Ltd

Selective Supplies Ltd

Stirling Anglian Pharmaceuticals Ltd

Strides Pharma UK Ltd

Sun Pharma UK Ltd

Synchrony

Takeda UK Ltd

Teva UK Limited

Thea Pharmaceuticals Limited

Thornton and Ross Ltd

Tillomed Laboratories ltd

Torbay Pharmaceuticals

Torrent Pharma UK Ltd

VIATRIS UK HEALTHCARE LIMITED

Vantage Pharmaceuticals Ltd

Waymade PLC

Wockhardt UK Limited

Zentiva Pharma UK Ltd

Zydus Pharmaceuticals UK Ltd

medac Pharma LLP

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...